Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Biotheus Inc. logo — To Inspire Each Other and Create Effective Medicines for Hum...

Biotheus Inc.

To Inspire Each Other and Create Effective Medicines for Humankind

Founded 2018 China Zhuhai, China 24 employees Acquired Total: $919.50M Biotechnology, Health Care

General Information

Company Name Biotheus Inc.
Founded Year 2018
Location China Zhuhai, China
Employees 24
Industries Biotechnology, Health Care
Funding Stage Acquired
Social

BounceWatch is an independent company data service, not affiliated with Biotheus Inc.. To contact Biotheus Inc., visit biotheus.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Biotheus Inc. compare?

A PDF of Biotheus Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Biotheus Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Biotheus Inc.

Biotheus Inc., founded in 2018, operates at the intersection of Biotechnology and Health Care. Based in China, the company is committed to its inspiring mission: "To Inspire Each Other and Create Effective Medicines for Humankind."

The core focus of Biotheus Inc. is the discovery and development of therapeutic biologics aimed at combating cancer and inflammatory diseases. They leverage creative scientific and industrial-academic collaborations to achieve these ambitious goals, underscoring a unique approach to innovation in the biotech industry.

In a significant financial milestone, Biotheus Inc. received an $800.00M acquisition investment on 01 November 2024, with BioNTech as a key investor. This substantial investment underscores confidence in Biotheus Inc.'s potential to deliver groundbreaking medical solutions.

Business keywords: Therapeutic Biologics, Cancer Treatment, Inflammatory Diseases, Biotech, Multispecific Antibodies, Antibody Discovery, Biologics R&D, Immuno-oncology, Tumor Biology, Autoimmune Diseases, Antibody Engineering, Drug Discovery, Drug Development, CMC Development, Pilot Plant

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Acquisition $800.00M 1
BioNTech
BioNTech
01 Nov 2024
Late VC $100.00M 9
General Atlantic Cowin Capital HighLight Capital
General Atlantic, Cowin Capital +7
01 Mar 2021
Series B $5.00M 2
New Alliance Capital Hanne Capital
New Alliance Capital, Hanne Capital
01 Jun 2020
Seed $14.50M 1
Shiyu Capital
Shiyu Capital
01 Jun 2019

Biotheus Inc. Alternatives & Competitors

View All Alternatives
Biotheus Inc. vs
Sensei Bio
Sensei Bio United States

We follow the immune system’s teachings to discover new treatments that inspire the body to fight ca...

Series B
32 employees
Biotechnology, Health Care
Biotheus Inc. vs
Merus N.V.
Merus N.V. The Netherlands

Oncology company developing Biclonics® bispecific antibody therapeutics. See our Community Guideline...

Post-IPO Equity
185 employees
Biotechnology, Health Care
Biotheus Inc. vs
BioAtla, Inc.
BioAtla, Inc. United States

Safer, more effective drugs for cancer using a proprietary next generation antibody discovery and ev...

IPO
35 employees
Biotechnology, Health Care
View all alternatives

FAQ About Biotheus Inc.

To Inspire Each Other and Create Effective Medicines for Humankind
Biotheus Inc. was founded in 2018.
Biotheus Inc. is headquartered in Zhuhai, China.
Biotheus Inc. operates in Biotechnology and Health Care. Its work centres on Therapeutic Biologics, Cancer Treatment, Inflammatory Diseases and Biotech.
Biotheus Inc. has approximately 24 employees.
Biotheus Inc. has completed 4 funding rounds, raising a total of $919.50M. The latest funding stage is Acquired.
Top alternatives and competitors to Biotheus Inc. include Sensei Bio, Merus N.V., BioAtla, Inc., Kojin Therapeutics, OncoResponse. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Biotheus Inc. and Sensei Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Biotheus Inc., https://bouncewatch.com/company/biotheus-inc, updated 15 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes